Navigation Links
Cholesterol Drugs' Benefits Far Outweigh Side Effects, Review Finds
Date:8/6/2014

TUESDAY, Aug. 5, 2014 (HealthDay News) -- The benefits of long-term use of cholesterol-lowering statin drugs greatly outweigh the risks, according to a review of research published over 20 years.

Some experts fear that statins may be overused, but these new findings could offer reassurance to the more than 200 million people worldwide who take the drugs, the review authors said. Common statin medications include Crestor, Lipitor and Zocor.

"For most at-risk patients, the cardiovascular benefits far exceed the risks," study author Dr. Chintan Desai, a clinical cardiology fellow at the Johns Hopkins Hospital, said in a Hopkins news release.

They analyzed data from studies conducted since 1994 that included more than 150,000 middle-aged and elderly men and women who took statins and were followed for about five years. The results showed that long-term statin use slightly increased the risk of some side effects but did not increase the risk for others.

For example, there was little evidence of muscle aches and pains and only a slight increase in the risk of muscle inflammation. A serious condition featuring the rapid breakdown of muscle tissue was mainly associated with high doses of statins that are no longer recommended.

Long-term use of statins was associated with a modest increase in the risk of type 2 diabetes, but only among people who had other diabetes risk factors. People who took statins for a long time had low increased risk for dementia, blood clots, cataracts and fatigue.

The researchers also found that statin use offered some protection for people at risk for inflammation of the pancreas and for kidney disease caused by the dye used for some medical imaging procedures.

The study was published July 31 in the British Medical Journal.

More information

The U.S. National Library of Medicine has more about statins.

SOURCE: Johns Hopkins Medicine, news release, Aug. 1, 2014

--


'/>"/>
Copyright©2014 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. Eliminating the good cholesterol receptor may fight breast cancer
2. Cholesterol Levels Vary Widely by Country: Study
3. VCU researchers identify changes in cholesterol metabolic pathways
4. Intensive cholesterol therapy with multiple drugs effective over long term
5. Algae extract increases good cholesterol levels, Wayne State research finds
6. Doctors Spar Over Cholesterol Screening in Kids
7. Cholesterol Levels Getting Better for U.S. Kids: CDC
8. Photographic cholesterol test
9. Vitamin D Supplements Wont Help Cholesterol Levels: Study
10. Cholesterol Screenings Up, But Certain Groups Still Lag: CDC
11. Canadian scientists discover cause of high cholesterol
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Cholesterol Drugs' Benefits Far Outweigh Side Effects, Review Finds
(Date:12/5/2016)... ... December 05, 2016 , ... "FCPX Overlay Glare is ... natural lighting effect without heavy rendering or complicated compositing," said Christina Austin - CEO ... to create an organic spectrum of lights that simulates the look of a glare. ...
(Date:12/5/2016)... ... December 05, 2016 , ... The ... care facility – Avamere Transitional Care of Puget Sound ; located at ... health care center will provide patients recovering from illness or injury with intensive ...
(Date:12/5/2016)... VA (PRWEB) , ... December 05, 2016 , ... ... today announced it has been featured in SuperbCrew magazine, a leading online tech ... tech world. This interview, now featured on SuperbCrew.com, explores the state of enterprise ...
(Date:12/5/2016)... ... ... Researchers at Johns Hopkins All Children’s Hospital want to learn more about ... of three years, researchers will study concussions and changes in brain function by monitoring ... sensors, will track the location and force of the hit. The sensors store data ...
(Date:12/5/2016)... ... December 05, 2016 , ... “Epilepsy ... through tomorrow, December 6th, sparks a conversation about epilepsy, bearing down on the ... 26 people will be diagnosed with epilepsy within their lifetime. With such a ...
Breaking Medicine News(10 mins):
(Date:12/5/2016)... -- Sanovas, Inc., a life science asset holding ... its wholly owned subsidiary, Intubation Science, Inc., and its LightSpeed ... - http://photos.prnewswire.com/prnh/20161202/445251LOGO   ... Sanovas, Inc. ... There are over 40 million Endotracheal Intubations performed ...
(Date:12/5/2016)... 2016  CVS Health, the nation,s largest pharmacy innovation ... score of 100 percent on the Corporate Equality Index ... an annual national benchmarking survey and report on corporate ... the Human Rights Campaign Foundation. "Our ... colleagues, customers and suppliers bring to CVS Health," said ...
(Date:12/5/2016)... PARSIPPANY, N.J. , Dec. 5, 2016 /PRNewswire/ ... announced preliminary safety and efficacy data from a ... selective MDM2 inhibitor, suggesting that DS-3032 may be ... acute myeloid leukemia (AML) and high-risk myelodysplastic syndrome ... of the phase 1 study of DS-3032 were presented ...
Breaking Medicine Technology: